STOCK TITAN

[Form 4] The AZEK Company Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

AZEK – Form 4 (07/02/2025) documents the disposition of all AZEK equity held by Chief Human Resources Officer Sandra Lamartine in connection with the closing of the previously announced merger with James Hardie Industries plc (JHX) on 07/01/2025.

Common shares: 21,015 Class A shares were reported as disposed (Code “D”).
Equity awards: 42,262 performance-based RSUs and 33,339 stock-option awards (exercise prices ranging from $20.18 to $53.51) were likewise disposed of and converted into JHX instruments.

The filing reiterates final merger economics:

  • Cash Consideration: $26.45 per AZEK share.
  • Share Exchange Ratio: 1.0340 JHX ordinary shares per AZEK share.
  • Fractional shares settled in cash based on JHX’s 5-day VWAP of $26.053018.

All AZEK awards were assumed by JHX and converted into equivalent JHX restricted-stock, performance-unit or option awards using the same vesting schedules. Following conversion, the reporting person holds 0 AZEK securities; future ownership, if any, will be in JHX.

This Form 4 provides transactional confirmation that the merger closed and that AZEK equity has been fully exchanged, giving investors definitive consideration details and eliminating standalone AZEK insider ownership.

AZEK – Modulo 4 (07/02/2025) documenta la cessione di tutte le azioni AZEK detenute dal Chief Human Resources Officer Sandra Lamartine in relazione alla chiusura della fusione precedentemente annunciata con James Hardie Industries plc (JHX) il 01/07/2025.

Azioni ordinarie: 21.015 azioni di classe A sono state dichiarate cedute (Codice “D”).
Premi azionari: 42.262 RSU basate sulle performance e 33.339 opzioni su azioni (con prezzi di esercizio compresi tra $20,18 e $53,51) sono state anch’esse cedute e convertite in strumenti JHX.

Il deposito ribadisce le condizioni economiche finali della fusione:

  • Compenso in contanti: $26,45 per ogni azione AZEK.
  • Rapporto di scambio azionario: 1,0340 azioni ordinarie JHX per ogni azione AZEK.
  • Le azioni frazionarie sono state liquidate in contanti basandosi sulla media ponderata del prezzo di JHX negli ultimi 5 giorni, pari a $26,053018.

Tutti i premi AZEK sono stati assunti da JHX e convertiti in premi equivalenti in azioni vincolate, unità di performance o opzioni JHX, mantenendo gli stessi piani di maturazione. Dopo la conversione, la persona segnalante non detiene più titoli AZEK; ogni futura proprietà sarà in JHX.

Questo Modulo 4 conferma formalmente la chiusura della fusione e la completa conversione delle azioni AZEK, fornendo agli investitori dettagli definitivi sul compenso e eliminando la proprietà interna autonoma di AZEK.

AZEK – Formulario 4 (07/02/2025) documenta la disposición de todas las acciones de AZEK en poder de la Directora de Recursos Humanos, Sandra Lamartine, en relación con el cierre de la fusión previamente anunciada con James Hardie Industries plc (JHX) el 01/07/2025.

Acciones ordinarias: Se reportaron 21,015 acciones Clase A como dispuestas (Código “D”).
Premios en acciones: 42,262 RSU basadas en desempeño y 33,339 opciones sobre acciones (con precios de ejercicio entre $20.18 y $53.51) también fueron dispuestas y convertidas en instrumentos JHX.

La presentación reitera los términos económicos finales de la fusión:

  • Consideración en efectivo: $26.45 por acción de AZEK.
  • Ratio de intercambio de acciones: 1.0340 acciones ordinarias de JHX por cada acción de AZEK.
  • Las acciones fraccionarias se liquidaron en efectivo basándose en el VWAP de 5 días de JHX de $26.053018.

Todos los premios AZEK fueron asumidos por JHX y convertidos en premios equivalentes de acciones restringidas, unidades de rendimiento u opciones de JHX con los mismos calendarios de adquisición. Tras la conversión, la persona reportante no posee ningún valor AZEK; la propiedad futura, si la hubiera, será en JHX.

Este Formulario 4 proporciona confirmación transaccional del cierre de la fusión y de la completa conversión de las acciones AZEK, ofreciendo a los inversores detalles definitivos de la consideración y eliminando la propiedad interna independiente de AZEK.

AZEK – 양식 4 (2025년 7월 2일)는 인사 책임자 산드라 라마틴이 보유한 모든 AZEK 주식의 처분 내역을 2025년 7월 1일에 이전에 발표된 James Hardie Industries plc (JHX)와의 합병 종결과 관련하여 문서화한 것입니다.

보통주: 21,015주 클래스 A 주식이 처분됨(코드 “D”)으로 보고되었습니다.
주식 보상: 42,262개의 성과 기반 RSU와 33,339개의 주식 옵션(행사가격 $20.18에서 $53.51 사이)도 처분되어 JHX의 증권으로 전환되었습니다.

신고서에는 최종 합병 조건이 다시 명시되어 있습니다:

  • 현금 보상: AZEK 주당 $26.45.
  • 주식 교환 비율: AZEK 주식 1주당 JHX 보통주 1.0340주.
  • 소액 주식은 JHX의 5일 VWAP $26.053018을 기준으로 현금 정산되었습니다.

모든 AZEK 보상은 JHX가 인수하여 동일한 권리 확정 일정으로 JHX 제한 주식, 성과 단위 또는 옵션 보상으로 전환되었습니다. 전환 후 보고자는 AZEK 증권을 보유하지 않으며, 향후 보유 주식이 있다면 JHX 주식이 될 것입니다.

이 양식 4는 합병이 완료되었음을 거래적으로 확인하며 AZEK 주식이 완전히 교환되었음을 투자자에게 확정적으로 알리고 독립적인 AZEK 내부자 보유를 없애줍니다.

AZEK – Formulaire 4 (02/07/2025) documente la cession de toutes les actions AZEK détenues par la Directrice des Ressources Humaines Sandra Lamartine en lien avec la clôture de la fusion annoncée précédemment avec James Hardie Industries plc (JHX) le 01/07/2025.

Actions ordinaires : 21 015 actions de classe A ont été déclarées comme cédées (Code « D »).
Attributions d’actions : 42 262 RSU basées sur la performance et 33 339 options d’achat d’actions (prix d’exercice entre 20,18 $ et 53,51 $) ont également été cédées et converties en instruments JHX.

Le dépôt réitère les modalités économiques finales de la fusion :

  • Contrepartie en espèces : 26,45 $ par action AZEK.
  • Ratio d’échange d’actions : 1,0340 action ordinaire JHX par action AZEK.
  • Les actions fractionnaires ont été réglées en espèces sur la base du VWAP 5 jours de JHX à 26,053018 $.

Toutes les attributions AZEK ont été reprises par JHX et converties en attributions équivalentes d’actions restreintes, d’unités de performance ou d’options JHX selon les mêmes calendriers d’acquisition. Après conversion, la personne déclarant ne détient plus aucun titre AZEK ; toute détention future, le cas échéant, sera en JHX.

Ce Formulaire 4 confirme transactionnellement la clôture de la fusion et la conversion complète des actions AZEK, fournissant aux investisseurs des détails définitifs sur la contrepartie et éliminant la détention interne autonome d’AZEK.

AZEK – Formular 4 (02.07.2025) dokumentiert die Veräußerung sämtlicher AZEK-Aktien, die von der Chief Human Resources Officer Sandra Lamartine im Zusammenhang mit dem Abschluss der zuvor angekündigten Fusion mit James Hardie Industries plc (JHX) am 01.07.2025 gehalten wurden.

Stammaktien: 21.015 Class A Aktien wurden als veräußert (Code „D“) gemeldet.
Aktienzuteilungen: 42.262 leistungsabhängige RSUs und 33.339 Aktienoptionen (Ausübungspreise von $20,18 bis $53,51) wurden ebenfalls veräußert und in JHX-Instrumente umgewandelt.

Die Einreichung bestätigt die endgültigen Fusionsbedingungen:

  • Bargeldzahlung: $26,45 pro AZEK-Aktie.
  • Aktientauschverhältnis: 1,0340 JHX-Stammaktien pro AZEK-Aktie.
  • Bruchstücke von Aktien wurden bar auf Basis des 5-Tage-Durchschnittskurses (VWAP) von JHX in Höhe von $26,053018 ausgeglichen.

Alle AZEK-Zuteilungen wurden von JHX übernommen und in entsprechende JHX Restricted Stock, Performance Units oder Optionszuteilungen mit den gleichen Vestingplänen umgewandelt. Nach der Umwandlung hält die meldende Person keine AZEK-Wertpapiere mehr; zukünftiger Besitz, falls vorhanden, wird in JHX sein.

Dieses Formular 4 bestätigt den Abschluss der Fusion und die vollständige Umwandlung der AZEK-Anteile und liefert den Investoren endgültige Details zur Gegenleistung, wodurch ein eigenständiger interner Besitz von AZEK eliminiert wird.

Positive
  • Merger consummation confirmed, removing deal-completion risk for investors.
  • Clear consideration terms: $26.45 cash + 1.0340 JHX shares per AZEK share.
  • Employee equity preserved via 1-for-1 conversion to JHX instruments, supporting retention.
Negative
  • AZEK insider ownership reduced to zero, eliminating a traditional alignment signal with the legacy entity.

Insights

TL;DR – Filing confirms merger closing and exact payout terms.

The Form 4 is a mechanical but important post-closing record. It shows that AZEK share conversion is complete: each share yielded $26.45 cash plus 1.0340 JHX shares. Insider disposition code “D” is purely transactional, not indicative of voluntary selling. Equity awards were rolled into equivalent JHX instruments, preserving vesting and reducing employee flight risk. From an M&A perspective, this removes execution risk—consideration terms are now locked. The document thus validates the deal close, a key milestone for arbitrage investors.

TL;DR – Confirms liquidity event; AZEK equity ceases to exist.

For holders of AZEK, the filing signals that their value realization is now in cash and JHX stock. The fixed cash component delivers immediate liquidity, while the share portion transfers exposure to JHX’s fundamentals. Insider ownership of AZEK drops to zero, eliminating an alignment metric, but award rollover suggests continuity in the combined firm’s leadership incentives. Market impact is modest because terms were pre-announced, yet confirmation reduces residual uncertainty and may prompt final index and portfolio rebalancing.

AZEK – Modulo 4 (07/02/2025) documenta la cessione di tutte le azioni AZEK detenute dal Chief Human Resources Officer Sandra Lamartine in relazione alla chiusura della fusione precedentemente annunciata con James Hardie Industries plc (JHX) il 01/07/2025.

Azioni ordinarie: 21.015 azioni di classe A sono state dichiarate cedute (Codice “D”).
Premi azionari: 42.262 RSU basate sulle performance e 33.339 opzioni su azioni (con prezzi di esercizio compresi tra $20,18 e $53,51) sono state anch’esse cedute e convertite in strumenti JHX.

Il deposito ribadisce le condizioni economiche finali della fusione:

  • Compenso in contanti: $26,45 per ogni azione AZEK.
  • Rapporto di scambio azionario: 1,0340 azioni ordinarie JHX per ogni azione AZEK.
  • Le azioni frazionarie sono state liquidate in contanti basandosi sulla media ponderata del prezzo di JHX negli ultimi 5 giorni, pari a $26,053018.

Tutti i premi AZEK sono stati assunti da JHX e convertiti in premi equivalenti in azioni vincolate, unità di performance o opzioni JHX, mantenendo gli stessi piani di maturazione. Dopo la conversione, la persona segnalante non detiene più titoli AZEK; ogni futura proprietà sarà in JHX.

Questo Modulo 4 conferma formalmente la chiusura della fusione e la completa conversione delle azioni AZEK, fornendo agli investitori dettagli definitivi sul compenso e eliminando la proprietà interna autonoma di AZEK.

AZEK – Formulario 4 (07/02/2025) documenta la disposición de todas las acciones de AZEK en poder de la Directora de Recursos Humanos, Sandra Lamartine, en relación con el cierre de la fusión previamente anunciada con James Hardie Industries plc (JHX) el 01/07/2025.

Acciones ordinarias: Se reportaron 21,015 acciones Clase A como dispuestas (Código “D”).
Premios en acciones: 42,262 RSU basadas en desempeño y 33,339 opciones sobre acciones (con precios de ejercicio entre $20.18 y $53.51) también fueron dispuestas y convertidas en instrumentos JHX.

La presentación reitera los términos económicos finales de la fusión:

  • Consideración en efectivo: $26.45 por acción de AZEK.
  • Ratio de intercambio de acciones: 1.0340 acciones ordinarias de JHX por cada acción de AZEK.
  • Las acciones fraccionarias se liquidaron en efectivo basándose en el VWAP de 5 días de JHX de $26.053018.

Todos los premios AZEK fueron asumidos por JHX y convertidos en premios equivalentes de acciones restringidas, unidades de rendimiento u opciones de JHX con los mismos calendarios de adquisición. Tras la conversión, la persona reportante no posee ningún valor AZEK; la propiedad futura, si la hubiera, será en JHX.

Este Formulario 4 proporciona confirmación transaccional del cierre de la fusión y de la completa conversión de las acciones AZEK, ofreciendo a los inversores detalles definitivos de la consideración y eliminando la propiedad interna independiente de AZEK.

AZEK – 양식 4 (2025년 7월 2일)는 인사 책임자 산드라 라마틴이 보유한 모든 AZEK 주식의 처분 내역을 2025년 7월 1일에 이전에 발표된 James Hardie Industries plc (JHX)와의 합병 종결과 관련하여 문서화한 것입니다.

보통주: 21,015주 클래스 A 주식이 처분됨(코드 “D”)으로 보고되었습니다.
주식 보상: 42,262개의 성과 기반 RSU와 33,339개의 주식 옵션(행사가격 $20.18에서 $53.51 사이)도 처분되어 JHX의 증권으로 전환되었습니다.

신고서에는 최종 합병 조건이 다시 명시되어 있습니다:

  • 현금 보상: AZEK 주당 $26.45.
  • 주식 교환 비율: AZEK 주식 1주당 JHX 보통주 1.0340주.
  • 소액 주식은 JHX의 5일 VWAP $26.053018을 기준으로 현금 정산되었습니다.

모든 AZEK 보상은 JHX가 인수하여 동일한 권리 확정 일정으로 JHX 제한 주식, 성과 단위 또는 옵션 보상으로 전환되었습니다. 전환 후 보고자는 AZEK 증권을 보유하지 않으며, 향후 보유 주식이 있다면 JHX 주식이 될 것입니다.

이 양식 4는 합병이 완료되었음을 거래적으로 확인하며 AZEK 주식이 완전히 교환되었음을 투자자에게 확정적으로 알리고 독립적인 AZEK 내부자 보유를 없애줍니다.

AZEK – Formulaire 4 (02/07/2025) documente la cession de toutes les actions AZEK détenues par la Directrice des Ressources Humaines Sandra Lamartine en lien avec la clôture de la fusion annoncée précédemment avec James Hardie Industries plc (JHX) le 01/07/2025.

Actions ordinaires : 21 015 actions de classe A ont été déclarées comme cédées (Code « D »).
Attributions d’actions : 42 262 RSU basées sur la performance et 33 339 options d’achat d’actions (prix d’exercice entre 20,18 $ et 53,51 $) ont également été cédées et converties en instruments JHX.

Le dépôt réitère les modalités économiques finales de la fusion :

  • Contrepartie en espèces : 26,45 $ par action AZEK.
  • Ratio d’échange d’actions : 1,0340 action ordinaire JHX par action AZEK.
  • Les actions fractionnaires ont été réglées en espèces sur la base du VWAP 5 jours de JHX à 26,053018 $.

Toutes les attributions AZEK ont été reprises par JHX et converties en attributions équivalentes d’actions restreintes, d’unités de performance ou d’options JHX selon les mêmes calendriers d’acquisition. Après conversion, la personne déclarant ne détient plus aucun titre AZEK ; toute détention future, le cas échéant, sera en JHX.

Ce Formulaire 4 confirme transactionnellement la clôture de la fusion et la conversion complète des actions AZEK, fournissant aux investisseurs des détails définitifs sur la contrepartie et éliminant la détention interne autonome d’AZEK.

AZEK – Formular 4 (02.07.2025) dokumentiert die Veräußerung sämtlicher AZEK-Aktien, die von der Chief Human Resources Officer Sandra Lamartine im Zusammenhang mit dem Abschluss der zuvor angekündigten Fusion mit James Hardie Industries plc (JHX) am 01.07.2025 gehalten wurden.

Stammaktien: 21.015 Class A Aktien wurden als veräußert (Code „D“) gemeldet.
Aktienzuteilungen: 42.262 leistungsabhängige RSUs und 33.339 Aktienoptionen (Ausübungspreise von $20,18 bis $53,51) wurden ebenfalls veräußert und in JHX-Instrumente umgewandelt.

Die Einreichung bestätigt die endgültigen Fusionsbedingungen:

  • Bargeldzahlung: $26,45 pro AZEK-Aktie.
  • Aktientauschverhältnis: 1,0340 JHX-Stammaktien pro AZEK-Aktie.
  • Bruchstücke von Aktien wurden bar auf Basis des 5-Tage-Durchschnittskurses (VWAP) von JHX in Höhe von $26,053018 ausgeglichen.

Alle AZEK-Zuteilungen wurden von JHX übernommen und in entsprechende JHX Restricted Stock, Performance Units oder Optionszuteilungen mit den gleichen Vestingplänen umgewandelt. Nach der Umwandlung hält die meldende Person keine AZEK-Wertpapiere mehr; zukünftiger Besitz, falls vorhanden, wird in JHX sein.

Dieses Formular 4 bestätigt den Abschluss der Fusion und die vollständige Umwandlung der AZEK-Anteile und liefert den Investoren endgültige Details zur Gegenleistung, wodurch ein eigenständiger interner Besitz von AZEK eliminiert wird.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
NAGEL VERNON J

(Last) (First) (Middle)
1330 W. FULTON ST.
SUITE 350

(Street)
CHICAGO IL 60607

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AZEK Co Inc. [ AZEK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 07/01/2025 D 23,209(1) D (2)(3) 0 D
Class A Common Stock 07/01/2025 D 21,972(1)(4) D (4) 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares (including in respect of shares underlying, as applicable, Company RSU Awards, Company PSU Awards and Company Stock Options (each as defined in the Agreement and Plan of Merger, dated as of March 23, 2025 (as amended, the "Merger Agreement"), by and among The AZEK Company Inc. ("AZEK"), James Hardie Industries plc ("JHX") and Juno Merger Sub Inc.)) disposed of pursuant to the closing of the transactions contemplated by the Merger Agreement.
2. In accordance with the Merger Agreement, upon the Effective Time (as defined in the Merger Agreement), each share of Company Common Stock (as defined in the Merger Agreement) that was issued and outstanding immediately prior to the Effective Time (subject to certain exceptions) was converted into the right to receive $26.45 in cash, without interest (the "Cash Consideration"), and 1.0340 (the "Exchange Ratio") JHX ordinary shares, with cash in lieu of fractional JHX ordinary shares, where any such aggregated fractional shares are rounded to four (4) decimal places and multiplied by JHX's five-trading day volume-weighted average price ending on June 30, 2025, the trading day immediately prior to the closing of the transactions contemplated by the Merger Agreement (the "Parent Share Price") (collectively, the "Merger Consideration"). The Parent Share Price was $26.053018.
3. Upon the Effective Time, each then-outstanding Company RSU Award held by the reporting person was fully vested and canceled in exchange for the right to receive the Merger Consideration.
4. In connection with the closing of the merger, the deferred stock units held by the reporting person as of immediately prior to the Effective Time were settled and immediately cancelled in exchange for the Merger Consideration.
/s/ Morgan Walbridge, as Attorney-in-Fact for Vernon J. Nagel 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What consideration did AZEK (AZEK) shareholders receive at closing?

Each AZEK share was exchanged for $26.45 in cash and 1.0340 JHX ordinary shares.

When did the AZEK–JHX merger close?

The effective closing date reflected in the filing is July 1, 2025.

What happened to AZEK stock options and RSUs held by insiders?

All awards were assumed by JHX and converted into equivalent JHX options or RSUs with the original vesting schedules.

Does Sandra Lamartine hold any AZEK shares after the transaction?

No. The Form 4 shows 0 AZEK securities remaining; future holdings are in JHX.

How was cash paid for fractional JHX shares?

Fractional shares were settled in cash based on JHX’s five-day VWAP of $26.053018.
Azek Co Inc

NYSE:AZEK

AZEK Rankings

AZEK Latest News

AZEK Latest SEC Filings

AZEK Stock Data

7.59B
140.90M
1.79%
103.34%
3.85%
Building Products & Equipment
Plastics Products, Nec
Link
United States
CHICAGO